Basic Information
LncRNA/CircRNA Name | BCAR4 |
Synonyms | NA |
Region | GRCh38_16:11819829-11828845 |
Ensemble | ENSG00000262117 |
Refseq | NR_024049 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, Cell proliferation assay etc. |
Sample | primary breast cancer tissues, cell lines (ZR-75-1,IPH-926 etc.) |
Expression Pattern | up-regulated |
Function Description | Relative high BCAR4 mRNA expression was identified in IPH-926, a cell line derived from an endocrine-resistant lobular breast cancer. Moderate BCAR4 expression was evident in MDA-MB-134 and MDA-MB-453 breast cancer cells. BCAR4 protein was detected in breast cancer cells with ectopic (ZR-75-1-BCAR4) and endogenous (IPH-926, MDA-MB-453) BCAR4 mRNA expression. Knockdown of BCAR4 inhibited cell proliferation. |
Pubmed ID | 26317614 |
Year | 2015 |
Title | Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells. |
External Links
Links for BCAR4 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |